BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12074787)

  • 1. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
    Hotakainen K; Haglund C; Paju A; Nordling S; Alfthan H; Rintala E; Stenman UH
    Eur Urol; 2002 Jun; 41(6):677-85. PubMed ID: 12074787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of messenger RNA for the beta-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reaction.
    Hotakainen K; Lintula S; Stenman J; Rintala E; Lindell O; Stenman UH
    Int J Cancer; 1999 Jun; 84(3):304-8. PubMed ID: 10371351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
    Bialkowska-Hobrzanska H; Bowles L; Bukala B; Joseph MG; Fletcher R; Razvi H
    Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder.
    Hazzaa SM; Elashry OM; Afifi IK
    Pathol Oncol Res; 2010 Mar; 16(1):101-9. PubMed ID: 19757199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
    Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of human chorionic gonadotropin beta genes 3, 5 and 8 in tumor tissue and urinary cells of bladder cancer patients.
    Hotakainen K; Lintula S; Jarvinen R; Paju A; Stenman J; Rintala E; Stenman UH
    Tumour Biol; 2007; 28(1):52-6. PubMed ID: 17139196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hecate-CGbeta conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-alpha promoter.
    Vuorenoja S; Mohanty BP; Arola J; Huhtaniemi I; Toppari J; Rahman NA
    Endocr Relat Cancer; 2009 Jun; 16(2):549-64. PubMed ID: 19261682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary hCG beta-core fragment as a tumor marker for bladder cancer].
    Yamanaka N; Kawabata G; Morisue K; Hazama M; Nishimura R
    Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):700-6. PubMed ID: 8492514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.
    Okegawa T; Kinjo M; Horie S; Nutahara K; Higashihara E
    Urology; 2003 Jul; 62(1):182-6. PubMed ID: 12837463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential molecular marker for detecting transitional cell carcinoma.
    Chiu AW; Huang YL; Huan SK; Wang YC; Ju JP; Chen MF; Chou CK
    Urology; 2002 Jul; 60(1):181-5. PubMed ID: 12100959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
    Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
    Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
    Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
    Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine.
    Seripa D; Parrella P; Gallucci M; Gravina C; Papa S; Fortunato P; Alcini A; Flammia G; Lazzari M; Fazio VM
    Int J Cancer; 2001 Nov; 95(6):364-9. PubMed ID: 11668518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of maspin expression in bladder cancer.
    Beecken WD; Engl T; Engels K; Blumenberg C; Oppermann E; Camphausen K; Shing Y; Reinecke G; Jonas D; Blaheta R
    World J Urol; 2006 Aug; 24(3):338-44. PubMed ID: 16832651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy?
    Moutzouris G; Yannopoulos D; Barbatis C; Zaharof A; Theodorou C
    Br J Urol; 1993 Dec; 72(6):907-9. PubMed ID: 7508330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.